Clinical Trial Update: Treatment With Acamprosate in Patients With Schizophrenia and Comorbid Alcoholism [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating acamprosate in patients with schizophrenia and comorbid alcoholism has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Dependence
• Schizophrenia

Drugs mentioned

• acamprosate (acamprosate)

Snippet

Sponsor: Yale University | Conditions: Alcohol Dependence, Schizophrenia | Phase 3 | Status: COMPLETED | Results posted: 2016-01-15